- Home
- MRNA vs ORLY Comparison
MRNA vs ORLY Comparison
Compare MRNA & ORLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | ORLY |
|---|---|---|
| Founded | 2010 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto & Home Supply Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6B | 72.0B |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MRNA | ORLY |
|---|---|---|
| Price | $182.10 | $85.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 17 |
| Target Price | $34.27 | ★ $111.59 |
| AVG Volume (30 Days) | ★ 16.6M | 4.9M |
| Earning Date | 05-01-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ 1.58 |
| Revenue | ★ $19,263,000,000.00 | $17,781,992,000.00 |
| Revenue This Year | $9.36 | $8.67 |
| Revenue Next Year | $15.43 | $6.22 |
| P/E Ratio | ★ N/A | $52.46 |
| Revenue Growth | 4.29 | ★ 6.42 |
| 52 Week Low | $22.28 | $82.59 |
| 52 Week High | $176.86 | $108.72 |
Technical Indicators
Market Signals| Indicator | MRNA | ORLY |
|---|---|---|
| Relative Strength Index (RSI) | 68.50 | 41.42 |
| Support Level | $46.85 | $82.65 |
| Resistance Level | $176.66 | $93.59 |
| Average True Range (ATR) | 9.39 | 1.54 |
| MACD | 0.06 | -0.26 |
| Stochastic Oscillator | 87.11 | 28.52 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About ORLY O'Reilly Automotive Inc.
O'Reilly is an aftermarket automotive parts retailer in the United States and Mexico with more than $16 billion in annual sales. The company operates over 6,000 domestic stores and serves both the do-it-yourself (about 50% of sales) and professional (47% of sales) end markets. O'Reilly differentiates itself by providing quality service to its customers throughout the entirety of the vehicle diagnosis and purchasing process. Furthermore, the firm boasts an impressive hub-and-spoke distribution network designed to provide its localized store base with ample aftermarket part availability across a variety of vehicle makes and models.